- The Washington Times - Tuesday, November 6, 2012

Dear Sgt. Shaft:

I know that you are very interested in the safety of visually impaired veterans when taking their prescriptions. You understand all too well the danger of not reading prescription labels and the possibility of making a tragic mistake. As you know, the ScripTalk Talking Prescription System is now installed in all VA Medical Centers in U.S. There are tens of thousands of veterans receiving their prescriptions with an audible label that allows them to hear their prescription label information. Thanks for your help in getting the word out on this very important service.

I also wanted to give you an update on the private sector, and our progress in making this technology available to others outside the VA. More and more pharmacy chains and independent pharmacies are now offering ScripTalk as a value-added service to their visually impaired patients. We are now positively impacting the health and well-being of all visually impaired folks in the nation.

Thank you again for your positive contribution in making accessible prescriptions a reality inside and outside the VA.

David Raistrick
Envision America

Dear Dave:

I have been one of the blinded vets that have taken advantage of your wonderful product; however it is disgraceful that President Obama and his minions have not given the civilian blind the opportunity to take advantage of this product.

When I receive prescriptions from the VA, because of your product, I hear the name of the prescription and the instructions on how to take the medication. Mr. President and members of Congress, please make sure the civilian blind can also take their prescriptions safely.

Shaft notes

• The Sarge is hoping that Joe Vet gets help from this study.

The Department of Veterans Affairs and the Department of Defense (DoD) are investing more than $100 million in research to improve diagnosis and treatment of mild Traumatic Brain Injury (mTBI) and Post-traumatic Stress Disorder (PTSD).

“At VA, ensuring that our veterans receive quality care is our highest priority,” said Secretary Eric K. Shinseki. “Investing in innovative research that will lead to treatments for PTSD and TBI is critical to providing the care our veterans have earned and deserve.”

The two groups, The Consortium to Alleviate PTSD (CAP) and the Chronic Effects of Neurotrauma Consortium (CENC), will be jointly managed by VA and by the Congressionally Directed Medical Research Programs (CDMRP), on behalf of the DoD.

More than 15 percent of service members and veterans suffer impaired functioning as a result of PTSD. CAP will study potential indicators of the trauma, as well as prevention strategies, possible interventions and improved treatments. Biomarker-based researched will be a key factor for CAP’s studies.

A primary goal of CENC is to establish an understanding of the aftereffects of an mTBI. Potential comorbidities also will be studied; that is, conditions associated with and worsen because of a neurotrauma.

Story Continues →